An artificial intelligence (AI) -based diagnostic system, LungDiag, to diagnose respiratory diseases.
Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq | Psychedelic Invest
NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on September 12, 2024, the Company received a staff determination letter (the “Determination